 | • レポートコード：QFJ1-4800 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、直腸がん治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・直腸がん治療薬の市場動向 ・企業の競争状況、市場シェア ・直腸がん治療薬の種類別市場規模と予測2016-2027（医薬品、手術、その他） ・直腸がん治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・直腸がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・直腸がん治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・直腸がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・直腸がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・直腸がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Eli Lilly and Company、Taiwan Liposome、Genentech、Sanofi-aventis Groupe、Merck、Bristol-Myers Squibb、Hutchison MediPharma、Seattle Genetics、Advaxis、Pfizer、AstraZeneca） ・結論 |
Rectal cancer is a disease in which malignant (cancer) cells form in the tissues of the rectum.
Market Analysis and Insights: Global Rectal Cancer Therapeutics Market
The global Rectal Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rectal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rectal Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rectal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rectal Cancer Therapeutics market.
Global Rectal Cancer Therapeutics Scope and Market Size
Rectal Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rectal Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Eli Lilly and Company
Taiwan Liposome
Genentech
Sanofi-aventis Groupe
Merck
Bristol-Myers Squibb
Hutchison MediPharma
Seattle Genetics
Advaxis
Pfizer
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rectal Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Rectal Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Rectal Cancer Therapeutics Market Perspective (2016-2027)
2.2 Rectal Cancer Therapeutics Growth Trends by Regions
2.2.1 Rectal Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Rectal Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Rectal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Rectal Cancer Therapeutics Industry Dynamic
2.3.1 Rectal Cancer Therapeutics Market Trends
2.3.2 Rectal Cancer Therapeutics Market Drivers
2.3.3 Rectal Cancer Therapeutics Market Challenges
2.3.4 Rectal Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rectal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Rectal Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Rectal Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Rectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Rectal Cancer Therapeutics Revenue
3.4 Global Rectal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Rectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rectal Cancer Therapeutics Revenue in 2020
3.5 Rectal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Rectal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Rectal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Rectal Cancer Therapeutics Breakdown Data by Type
4.1 Global Rectal Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Rectal Cancer Therapeutics Breakdown Data by Application
5.1 Global Rectal Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Rectal Cancer Therapeutics Market Size (2016-2027)
6.2 North America Rectal Cancer Therapeutics Market Size by Type
6.2.1 North America Rectal Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Rectal Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Rectal Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Rectal Cancer Therapeutics Market Size by Application
6.3.1 North America Rectal Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Rectal Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Rectal Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Rectal Cancer Therapeutics Market Size by Country
6.4.1 North America Rectal Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Rectal Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Rectal Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Rectal Cancer Therapeutics Market Size by Type
7.2.1 Europe Rectal Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Rectal Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Rectal Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Rectal Cancer Therapeutics Market Size by Application
7.3.1 Europe Rectal Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Rectal Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Rectal Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Rectal Cancer Therapeutics Market Size by Country
7.4.1 Europe Rectal Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Rectal Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Rectal Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Rectal Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Rectal Cancer Therapeutics Market Size by Type
9.2.1 Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Rectal Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Rectal Cancer Therapeutics Market Size by Application
9.3.1 Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Rectal Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Rectal Cancer Therapeutics Market Size by Country
9.4.1 Latin America Rectal Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Rectal Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rectal Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Rectal Cancer Therapeutics Introduction
11.1.4 Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.1.5 Eli Lilly and Company Recent Development
11.2 Taiwan Liposome
11.2.1 Taiwan Liposome Company Details
11.2.2 Taiwan Liposome Business Overview
11.2.3 Taiwan Liposome Rectal Cancer Therapeutics Introduction
11.2.4 Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.2.5 Taiwan Liposome Recent Development
11.3 Genentech
11.3.1 Genentech Company Details
11.3.2 Genentech Business Overview
11.3.3 Genentech Rectal Cancer Therapeutics Introduction
11.3.4 Genentech Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.3.5 Genentech Recent Development
11.4 Sanofi-aventis Groupe
11.4.1 Sanofi-aventis Groupe Company Details
11.4.2 Sanofi-aventis Groupe Business Overview
11.4.3 Sanofi-aventis Groupe Rectal Cancer Therapeutics Introduction
11.4.4 Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.4.5 Sanofi-aventis Groupe Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Rectal Cancer Therapeutics Introduction
11.5.4 Merck Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Rectal Cancer Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Hutchison MediPharma
11.7.1 Hutchison MediPharma Company Details
11.7.2 Hutchison MediPharma Business Overview
11.7.3 Hutchison MediPharma Rectal Cancer Therapeutics Introduction
11.7.4 Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.7.5 Hutchison MediPharma Recent Development
11.8 Seattle Genetics
11.8.1 Seattle Genetics Company Details
11.8.2 Seattle Genetics Business Overview
11.8.3 Seattle Genetics Rectal Cancer Therapeutics Introduction
11.8.4 Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.8.5 Seattle Genetics Recent Development
11.9 Advaxis
11.9.1 Advaxis Company Details
11.9.2 Advaxis Business Overview
11.9.3 Advaxis Rectal Cancer Therapeutics Introduction
11.9.4 Advaxis Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.9.5 Advaxis Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Rectal Cancer Therapeutics Introduction
11.10.4 Pfizer Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Rectal Cancer Therapeutics Introduction
11.11.4 AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2016-2021)
11.11.5 AstraZeneca Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Rectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Rectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Rectal Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Rectal Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Rectal Cancer Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Rectal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Rectal Cancer Therapeutics Market Share by Regions (2022-2027)
Table 11. Rectal Cancer Therapeutics Market Trends
Table 12. Rectal Cancer Therapeutics Market Drivers
Table 13. Rectal Cancer Therapeutics Market Challenges
Table 14. Rectal Cancer Therapeutics Market Restraints
Table 15. Global Rectal Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Rectal Cancer Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2020)
Table 18. Ranking of Global Top Rectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Rectal Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Rectal Cancer Therapeutics Product Solution and Service
Table 22. Date of Enter into Rectal Cancer Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Rectal Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Rectal Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Rectal Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Rectal Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Rectal Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Rectal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Rectal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Rectal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Eli Lilly and Company Company Details
Table 63. Eli Lilly and Company Business Overview
Table 64. Eli Lilly and Company Rectal Cancer Therapeutics Product
Table 65. Eli Lilly and Company Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Eli Lilly and Company Recent Development
Table 67. Taiwan Liposome Company Details
Table 68. Taiwan Liposome Business Overview
Table 69. Taiwan Liposome Rectal Cancer Therapeutics Product
Table 70. Taiwan Liposome Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Taiwan Liposome Recent Development
Table 72. Genentech Company Details
Table 73. Genentech Business Overview
Table 74. Genentech Rectal Cancer Therapeutics Product
Table 75. Genentech Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Genentech Recent Development
Table 77. Sanofi-aventis Groupe Company Details
Table 78. Sanofi-aventis Groupe Business Overview
Table 79. Sanofi-aventis Groupe Rectal Cancer Therapeutics Product
Table 80. Sanofi-aventis Groupe Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Sanofi-aventis Groupe Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Rectal Cancer Therapeutics Product
Table 85. Merck Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Rectal Cancer Therapeutics Product
Table 90. Bristol-Myers Squibb Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Hutchison MediPharma Company Details
Table 93. Hutchison MediPharma Business Overview
Table 94. Hutchison MediPharma Rectal Cancer Therapeutics Product
Table 95. Hutchison MediPharma Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Hutchison MediPharma Recent Development
Table 97. Seattle Genetics Company Details
Table 98. Seattle Genetics Business Overview
Table 99. Seattle Genetics Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Seattle Genetics Recent Development
Table 101. Advaxis Company Details
Table 102. Advaxis Business Overview
Table 103. Advaxis Rectal Cancer Therapeutics Product
Table 104. Advaxis Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Advaxis Recent Development
Table 106. Pfizer Company Details
Table 107. Pfizer Business Overview
Table 108. Pfizer Rectal Cancer Therapeutics Product
Table 109. Pfizer Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Pfizer Recent Development
Table 111. AstraZeneca Company Details
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Rectal Cancer Therapeutics Product
Table 114. AstraZeneca Revenue in Rectal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 115. AstraZeneca Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rectal Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Rectal Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Rectal Cancer Therapeutics Report Years Considered
Figure 10. Global Rectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Rectal Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Rectal Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Rectal Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Rectal Cancer Therapeutics Market Share by Players in 2020
Figure 15. Global Top Rectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rectal Cancer Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Rectal Cancer Therapeutics Revenue in 2020
Figure 17. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Rectal Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Rectal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Rectal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Rectal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Rectal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Rectal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Rectal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Rectal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Rectal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Rectal Cancer Therapeutics Market Share by Region (2016-2027)
Figure 39. China Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Rectal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Rectal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Rectal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Rectal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Rectal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Rectal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Rectal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Eli Lilly and Company Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 59. Taiwan Liposome Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 60. Genentech Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 61. Sanofi-aventis Groupe Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 64. Hutchison MediPharma Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 65. Seattle Genetics Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 66. Advaxis Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 68. AstraZeneca Revenue Growth Rate in Rectal Cancer Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の直腸がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing rectal cancer Market Analysis and Insights: Global Molecular Diagnosis of Rectal Cancer Market The global Molecular Diagnosis of Rectal Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.…- 世界の直腸カテーテル市場規模・現状・予測（2021年-2027年） The rectal catheter is a medical catheter used when uncontrolled bowel movement causes fecal incontinence. Market Analysis and Insights: Global Rectal Catheters Market The global Rectal Catheters market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% …
- 世界の直腸膣瘻治療市場規模・現状・予測（2021年-2027年） Rectovaginal fistula is abnormal connection between lower portion of large intestine- rectum-vagina. There are various causes of rectovaginal fistula such as Crohn's disease, cancer or radiation treatment in pelvic area, surgery involving vagina, perineum, rectum or anus, injuries during childbirth,…
- 世界の未分化甲状腺がん治療薬市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Therapeutics Market The global Anaplasti…
- 世界の胆嚢がん治療薬市場規模・現状・予測（2021年-2027年） Rising incidence of cholelithiasis, chronic inflammation of the gallbladder, and gallbladder polyps are contributing to the prevalence of gallbladder cancer. This has resulted in a rise in demand for therapeutics for treating the condition. Surgery is considered the primary treatment approach for ga…